POCI Quote, Financials, Valuation and Earnings

Perspective Therapeutics, Inc. has a net margin of -24.5% compared to Precision Optics Corp., Inc.'s net margin of -12425.36%. Precision Optics Corp., Inc.'s return on equity of -54.55% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.

Precision Optics Corp., Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 350.83%. Given that Perspective Therapeutics, Inc. has higher upside potential than Precision Optics Corp., Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than Precision Optics Corp., Inc..

Precision Optics Corp., Inc. has a beta of 0.265, which suggesting that the stock is 73.5% less volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.182, suggesting its more volatile than the S&P 500 by 18.151%.

Precision Optics Corp., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Precision Optics Corp., Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.

Precision Optics Corp., Inc. quarterly revenues are $6.7M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. Precision Optics Corp., Inc.'s net income of -$1.6M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Precision Optics Corp., Inc.'s price-to-earnings ratio is -- while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Precision Optics Corp., Inc. is 1.41x versus 185.11x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Daxor Corp. has a net margin of -24.5% compared to Precision Optics Corp., Inc.'s net margin of --. Precision Optics Corp., Inc.'s return on equity of -54.55% beat Daxor Corp.'s return on equity of 1.57%.

Precision Optics Corp., Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Daxor Corp. has an analysts' consensus of $22.00 which suggests that it could grow by 53.2%. Given that Daxor Corp. has higher upside potential than Precision Optics Corp., Inc., analysts believe Daxor Corp. is more attractive than Precision Optics Corp., Inc..

Precision Optics Corp., Inc. has a beta of 0.265, which suggesting that the stock is 73.5% less volatile than S&P 500. In comparison Daxor Corp. has a beta of -0.002, suggesting its less volatile than the S&P 500 by 100.211%.

Precision Optics Corp., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Daxor Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Precision Optics Corp., Inc. pays -- of its earnings as a dividend. Daxor Corp. pays out -- of its earnings as a dividend.

Precision Optics Corp., Inc. quarterly revenues are $6.7M, which are larger than Daxor Corp. quarterly revenues of --. Precision Optics Corp., Inc.'s net income of -$1.6M is higher than Daxor Corp.'s net income of --. Notably, Precision Optics Corp., Inc.'s price-to-earnings ratio is -- while Daxor Corp.'s PE ratio is 40.36x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Precision Optics Corp., Inc. is 1.41x versus 66.58x for Daxor Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Sanara MedTech, Inc. has a net margin of -24.5% compared to Precision Optics Corp., Inc.'s net margin of 3.17%. Precision Optics Corp., Inc.'s return on equity of -54.55% beat Sanara MedTech, Inc.'s return on equity of -20.48%.

Precision Optics Corp., Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Sanara MedTech, Inc. has an analysts' consensus of $41.00 which suggests that it could grow by 74.02%. Given that Sanara MedTech, Inc. has higher upside potential than Precision Optics Corp., Inc., analysts believe Sanara MedTech, Inc. is more attractive than Precision Optics Corp., Inc..

Precision Optics Corp., Inc. has a beta of 0.265, which suggesting that the stock is 73.5% less volatile than S&P 500. In comparison Sanara MedTech, Inc. has a beta of 1.062, suggesting its more volatile than the S&P 500 by 6.17%.

Precision Optics Corp., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sanara MedTech, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Precision Optics Corp., Inc. pays -- of its earnings as a dividend. Sanara MedTech, Inc. pays out -- of its earnings as a dividend.

Precision Optics Corp., Inc. quarterly revenues are $6.7M, which are smaller than Sanara MedTech, Inc. quarterly revenues of $26.3M. Precision Optics Corp., Inc.'s net income of -$1.6M is lower than Sanara MedTech, Inc.'s net income of $834.5K. Notably, Precision Optics Corp., Inc.'s price-to-earnings ratio is -- while Sanara MedTech, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Precision Optics Corp., Inc. is 1.41x versus 1.99x for Sanara MedTech, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Warby Parker, Inc. has a net margin of -24.5% compared to Precision Optics Corp., Inc.'s net margin of 2.65%. Precision Optics Corp., Inc.'s return on equity of -54.55% beat Warby Parker, Inc.'s return on equity of 0.2%.

Precision Optics Corp., Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Warby Parker, Inc. has an analysts' consensus of $26.33 which suggests that it could grow by 13.26%. Given that Warby Parker, Inc. has higher upside potential than Precision Optics Corp., Inc., analysts believe Warby Parker, Inc. is more attractive than Precision Optics Corp., Inc..

Precision Optics Corp., Inc. has a beta of 0.265, which suggesting that the stock is 73.5% less volatile than S&P 500. In comparison Warby Parker, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Precision Optics Corp., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Warby Parker, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Precision Optics Corp., Inc. pays -- of its earnings as a dividend. Warby Parker, Inc. pays out -- of its earnings as a dividend.

Precision Optics Corp., Inc. quarterly revenues are $6.7M, which are smaller than Warby Parker, Inc. quarterly revenues of $221.7M. Precision Optics Corp., Inc.'s net income of -$1.6M is lower than Warby Parker, Inc.'s net income of $5.9M. Notably, Precision Optics Corp., Inc.'s price-to-earnings ratio is -- while Warby Parker, Inc.'s PE ratio is 6,118.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Precision Optics Corp., Inc. is 1.41x versus 3.38x for Warby Parker, Inc.. Usually stocks with elevated PS ratios are considered overvalued.